Phenytoin-dexamethasone interaction: a previously unreported observation
- PMID: 7280966
- DOI: 10.1016/s0090-3019(81)80054-7
Phenytoin-dexamethasone interaction: a previously unreported observation
Abstract
A possible drug interaction between phenytoin and dexamethasone was evaluated by comparing serum phenytoin concentrations in 23 patients receiving both drugs with those of a control group of 15 patients receiving phenytoin only. Serum phenytoin concentrations obtained 24 hours after a loading dose of 11 mg per kilogram body weight administered intravenously and 13 mg/kg given intramuscularly were examined. The total amounts of dexamethasone administered during the 24-hour period ranged from 16 to 150 mg. The average serum phenytoin concentration was 17.28 +/- 3.49 micrograms/ml in patients receiving both drugs, as compared to 12.48 +/- 3.52 micrograms/ml in patients receiving only phenytoin (p less than 0.001). Our results suggest that serum phenytoin concentrations should be monitored in patients receiving concurrent dexamethasone therapy.
Similar articles
-
Interaction of dexamethasone with phenytoin.Pharmacotherapy. 1991;11(4):344-7. Pharmacotherapy. 1991. PMID: 1923918
-
Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1087-90. doi: 10.1136/jnnp.47.10.1087. J Neurol Neurosurg Psychiatry. 1984. PMID: 6502166 Free PMC article.
-
Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review.Ann Pharmacother. 1996 May;30(5):520-6. doi: 10.1177/106002809603000516. Ann Pharmacother. 1996. PMID: 8740335 Review.
-
Dexamethasone/phenytoin interactions: neurooncological concerns.Swiss Med Wkly. 2002 Jul 27;132(29-30):425-6. doi: 10.4414/smw.2002.10085. Swiss Med Wkly. 2002. PMID: 12428189 No abstract available.
-
Single-dose oral phenytoin loading.Ann Emerg Med. 1987 Apr;16(4):407-12. doi: 10.1016/s0196-0644(87)80360-8. Ann Emerg Med. 1987. PMID: 3826809 Clinical Trial.
Cited by
-
Clinical Relevance of Steroid Use in Neuro-Oncology.Curr Neurol Neurosci Rep. 2017 Jan;17(1):5. doi: 10.1007/s11910-017-0713-6. Curr Neurol Neurosci Rep. 2017. PMID: 28138871 Review.
-
Treatment options for brain metastases in patients with non-small-cell lung cancer.Curr Oncol Rep. 2003 Jul;5(4):342-6. doi: 10.1007/s11912-003-0077-8. Curr Oncol Rep. 2003. PMID: 12781078 Review.
-
Antiepileptic Drugs in the Management of Cerebral Metastases.Neurosurg Clin N Am. 2020 Oct;31(4):589-601. doi: 10.1016/j.nec.2020.06.008. Neurosurg Clin N Am. 2020. PMID: 32921354 Free PMC article. Review.
-
Medical management of brain tumors and the sequelae of treatment.Neuro Oncol. 2015 Apr;17(4):488-504. doi: 10.1093/neuonc/nou304. Epub 2014 Oct 30. Neuro Oncol. 2015. PMID: 25358508 Free PMC article. Review.
-
Brain metastases.Curr Treat Options Oncol. 2000 Dec;1(5):447-58. doi: 10.1007/s11864-000-0072-3. Curr Treat Options Oncol. 2000. PMID: 12057152 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources